Yang et al. reported that ginsenoside Rd (10–40 mg/kg) showed anti-inflammatory effects by lowering MPO and proinflammatory cytokine levels and inhibiting phosphorylation of p38 and JNK in a TNBS-induced rat colitis model [35]. Here, MAPK1 is linked to colitis.